Chairs: Amanda Proudfoot & Simon Jones
IL-23 regulation of innate and adaptive immunity (#S-28)
1:00 PM
Blocking only the bad side of Interleukin-6 (#S-21)
1:30 PM
STAT3: from fundamental discoveries to the clinic (#S-27)
2:00 PM
Exploiting receptor clustering enhances inhibitory effects of a therapeutic monoclonal antibody to TLR4 revealing a novel mechanism of action driving the pathology of rheumatoid arthritis. (#51)
2:30 PM
IL-7R: a target in ALL and autoimmunity (#245)
2:45 PM